Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients. (Q53556305)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients. |
scientific article |
Statements
Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients. (English)
John B A G Haanen
Adriaan Bins
Henk Mallo
Johan Sein
Colette van den Bogaard
Willem Nooijen
Florry Vyth-Dreese
Bastiaan Nuijen
Gijsbert C de Gast
1 February 2007
30
2
234-239